Press release
Motion Sickness Treatment Market Driven by Increasing Travel and Technological Advancements | to Reach US$ 900 Million by 2026 - TMR Insights
Motion Sickness Treatment
The global motion sickness treatment market was valued at US$ 670 million in 2017. It is projected to grow at a CAGR of 3% from 2018 to 2026, reaching approximately US$ 900 million by the end of the forecast period. The demand for motion sickness treatment is expected to rise due to increased travel activities, both for leisure and business purposes.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39320
Analyst Viewpoint
Market analysts foresee moderate yet steady growth in the motion sickness treatment market due to the increasing global travel population, expanding access to over-the-counter (OTC) medications, and the introduction of novel treatment options. However, the market may face challenges due to limited awareness in developing regions and potential side effects associated with medications.
Market Demand and Key Drivers
Growing Travel and Tourism Industry: The rise in global travel has increased the demand for motion sickness treatment solutions.
Availability of OTC Medications: Easy access to antihistamines and other treatments contributes to market expansion.
Technological Advancements: Innovations such as wearable devices and natural remedies are gaining traction.
Increased Awareness and Preventive Measures: Public education campaigns are encouraging the use of motion sickness medications and prevention strategies.
Expanding Geriatric Population: Older adults are more susceptible to motion sickness, increasing the need for effective treatments.
Recent Developments
2018, GlaxoSmithKline (GSK): Launched an advanced version of their motion sickness relief product.
2019, Pfizer: Entered into research partnerships for the development of non-drowsy motion sickness treatments.
2021, Bayer AG: Expanded distribution channels for its motion sickness product line.
2022, Prestige Consumer Healthcare: Acquired a motion sickness treatment brand to strengthen its portfolio.
Key Market Players
Perrigo Company
PLC
WellSpring Pharmaceutical Corporation
Myungmoon Pharm Co., Ltd.
Reliefband Technologies LLC
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39320
Market Trends and Opportunities
Rise of Natural and Herbal Remedies: Increasing consumer preference for organic treatment solutions.
Development of Non-Drowsy Formulations: Companies are innovating to minimize side effects.
Wearable Technology: Introduction of anti-nausea wristbands leveraging neuromodulation.
Expansion into Emerging Markets: Companies are targeting Asia-Pacific and Latin America for growth.
E-commerce Boom: Online sales of motion sickness treatment products are increasing due to convenience and accessibility.
Market Segmentation
By Treatment Type:
Antihistamines
Scopolamine Patches
Non-Pharmacological Therapy
Other Treatments
By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By End-User:
Adults
Children
Regional Analysis
North America: Dominates the market due to high travel frequency and advanced healthcare infrastructure.
Europe: Growing awareness and availability of OTC medications contribute to steady growth.
Asia-Pacific: Expected to witness significant growth due to rising disposable incomes and increased travel activity.
Latin America & Middle East/Africa: Increasing healthcare access and awareness drive market expansion.
Future Market Analysis
The motion sickness treatment market is expected to continue its upward trajectory, driven by advancements in drug formulations, the rise of digital health solutions, and the increasing adoption of wearable anti-nausea devices. Companies focusing on developing safer, more effective treatments with minimal side effects will gain a competitive advantage. Additionally, expanding market reach through online sales channels will further enhance growth opportunities.
Explore Latest Research Reports by Transparency Market Research:
Dental Gypsum Market- https://www.globenewswire.com/news-release/2024/03/14/2846441/32656/en/Dental-Gypsum-Market-Projected-to-Reach-USD-180-1-million-by-2031-Growing-at-a-CAGR-of-5-1-Transparency-Market-Research-Inc.html
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Motion Sickness Treatment Market Driven by Increasing Travel and Technological Advancements | to Reach US$ 900 Million by 2026 - TMR Insights here
News-ID: 3940991 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both…
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is…
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral…
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…
